Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Revenues        
Product $ 2,655 $ 2,503 $ 10,312 $ 8,379
Product licensing fees 702 94 1,125 318
Service 183 193 680 696
Total revenues 3,540 2,790 12,117 9,393
Cost of revenues        
Product 906 757 2,986 2,215
Service 163 181 576 599
Total cost of revenues 1,069 938 3,562 2,814
Gross profit 2,471 1,852 8,555 6,579
Operating expenses        
Research and development 509 509 1,554 1,505
Selling, general and administrative 2,642 3,697 8,993 10,076
Total operating expenses 3,151 4,206 10,547 11,581
Loss from operations (680) (2,354) (1,992) (5,002)
Interest expense (275) (260) (843) (652)
Interest income 1 1 3 4
Loss due to change in fair value of common stock (See Note 3) (864)    (864)   
(Loss) gain due to change in fair value of derivative instruments (84) 86 766 303
Other expense, net (10) (20) (56) (214)
Net loss (1,912) (2,547) (2,986) (5,561)
Preferred stock deemed dividend       (1,062)   
Net loss available to common shareholders (1,912) (2,547) (4,048) (5,561)
Net loss per common share: basic and diluted $ (0.05) $ (0.09) $ (0.12) $ (0.21)
Weighted-average number of shares used in per common share calculations:        
Basic and diluted 35,879 27,020 33,372 26,872
Other comprehensive loss, net of tax        
Net loss (1,912) (2,547) (2,986) (5,561)
Foreign currency translation adjustments (16) (87) (17) (261)
Other comprehensive loss $ (1,928) $ (2,634) $ (3,003) $ (5,822)